Robert K. Jenner brings more than three decades experience representing injured consumers nationwide against the manufacturers of dangerous prescription drugs, defective medical devices and tainted blood products.
Rob has been honored by Best Lawyers every year since 2006 and was in both 2013 and 2016 named Baltimore Mass Tort Litigation/Class Actions – Plaintiffs “Lawyer of the Year.” Rob has been named Lawyer of the Year (2013, 2016) and was named as one of America’s 50 Most Influential Trial Lawyers by the National Trial Lawyers (2017, 2018). He is also routinely honored in Maryland’s “Super Lawyers.”
In Rob’s legal practice, he began representing people who acquired HIV from blood and blood products. He authored the country’s first legal treatise on the subject, Transfusion–Associated AIDS (Lawyers & Judges Publishing Co., 1995). Rob continues his work on behalf of people living with HIV as he investigates claims against the manufacturer of tenofovir, a drug that caused unnecessary kidney disease and bone loss in tens of thousands of people world-wide. He is court appointed co-lead counsel working the tenofovir litigation in coordinated litigation in California (Gilead Tenofovir Cases, JCCP No. 5043, San Francisco).
The Superior Court for the Commonwealth of Massachusetts appointed Rob to serve on the Executive Committee of the consolidated claims of plaintiffs who were victims of the September 13, 2018, Merrimack Valley fire and gas explosions. The aggregate proceedings, known as In Re Columbia Gas Cases, are coordinated in the Salem Superior Court. Rob is also currently is Liaison Counsel for the Zofran litigation (MDL) in Boston; Liaison Counsel for the Smith & Nephew BHR hip implant litigation (MDL) in Baltimore; and serves on the Essure Plaintiffs’ Steering Committee of the California Judicial Council Coordinated Proceedings (JCCP) in Oakland, California.
Rob is a Past President of the Maryland Trial Lawyers Association (currently the Maryland Association for Justice, MAJ). In May 2009, MAJ Awarded he and his co-counsel its Trial Lawyer of the Year Award for their efforts in challenging the illegal subrogation practices of Maryland’s HMOs.
A significant portion of his commitment to the civil justice system is evidenced by Rob’s participation in the American Association for Justice (AAJ). He served as Chair of AAJ’s Publications Committee for 21 years, which oversees the publication of TRIAL magazine, the nation’s largest and most reputable magazine for trial lawyers. He is also a past Chair of AAJ’s Section on Toxic, Environmental and Pharmaceutical Torts. Rob currently serves as Co-Chair of AAJ’s Tenofovir Litigation Group, and AAJ’s Zofran Litigation Group. In addition, he has formerly served as Chair of the Pain Pump–Chondrolysis Litigation Group; Vice-Chair of the Hormone Therapy Litigation Group; Rezulin Litigation Group; Baycol Litigation Group; AIDS Litigation Group; Latex Toxicity Litigation Group; and HMO Litigation Group. In July 2002, 2003, 2004 and 2008, AAJ awarded him its Wiedemann-Wysocki Medal for his commitment to AAJ and the civil justice system.
He has written more than 25 articles published in nationally recognized legal and health care journals. Rob is also a frequent lecturer, having been invited to speak on medical/legal issues both nationally and internationally. He has organized and moderated dozens of acclaimed seminars in conjunction with AAJ’s National College of Advocacy on the issues of Zofran, Pradaxa, Vioxx, Hormone Therapy, Baycol, Rezulin, and general pharmaceutical and mass tort litigation.
Rob is a member of the bars of Maryland, Massachusetts, and the District of Columbia. He was honored by his peers by being inducted into the International Society of Barristers, one of the country’s most selective attorney honorary societies. He has obtained the highest rating (AV) by his peers as reflected in Martindale-Hubbell.
Rob is a volunteer for Lab Rescue of the LRCP, as well as an avid scuba diver and novice underwater photographer.